KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Neogenomics (NEO) Long-Term Debt Issuances (2018 - 2021)

Neogenomics (NEO) has disclosed Long-Term Debt Issuances for 4 consecutive years, with $334.4 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Long-Term Debt Issuances changed N/A year-over-year to $334.4 million, compared with a TTM value of $334.4 million through Dec 2021, up 71.96%, and an annual FY2021 reading of $334.4 million, up 71.96% over the prior year.
  • Long-Term Debt Issuances was $334.4 million for Q1 2021 at Neogenomics, up from $90000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $334.4 million in Q1 2021 and bottomed at -$100.0 million in Q4 2019.
  • Average Long-Term Debt Issuances over 3 years is $105.8 million, with a median of $100.0 million recorded in 2019.
  • Peak annual rise in Long-Term Debt Issuances hit 99.91% in 2020, while the deepest fall reached 99.91% in 2020.
  • Year by year, Long-Term Debt Issuances stood at -$100.0 million in 2019, then surged by 100.09% to $90000.0 in 2020, then surged by 371466.67% to $334.4 million in 2021.
  • Business Quant data shows Long-Term Debt Issuances for NEO at $334.4 million in Q1 2021, $90000.0 in Q3 2020, and $194.4 million in Q2 2020.